Form 4: Blackstone Entities Divest Medline Shares in Secondary Offering

Blackstone-affiliated entities and Stephen A. Schwarzman reported significant sales and in-kind distributions of Medline Inc. Class A Common Stock in connection with a secondary offering.

Summary

• BCP 8 Holdings Mozart Manager L.L.C., BMA VIII L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., Blackstone Inc., Blackstone Group Management L.L.C., and Stephen A. Schwarzman reported transactions involving Medline Inc. Class A Common Stock.
• On March 10, 2026, these reporting persons sold a total of 27,852,986 shares of Class A Common Stock.
• An additional 366,337 shares were distributed in-kind by Mozart Aggregator II LP to one of its investors and affiliated entities.
• The sales were executed at a price of $40.508 per share, which reflects the public offering price of $41.00 less underwriting discounts and commissions of $0.492 per share.
• These transactions were conducted in connection with the closing of a secondary offering of Medline Inc. Class A Common Stock.
• Following these transactions, the reporting persons collectively retain significant indirect beneficial ownership in Medline Inc., with various entities holding 109,250,239, 10,185, 12,507,704, 1,539, and 2,428,681 shares indirectly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a moderately negative signal due to significant insider selling by major beneficial owners, which can be interpreted as a reduction in conviction or a strategic divestment.

Negatives

• Significant sales of Class A Common Stock by major beneficial owners, including Blackstone-affiliated entities and Stephen A. Schwarzman, can be perceived as a negative signal by the market, potentially indicating a strategic divestment or reduced conviction.

Risks

• The complex indirect ownership structure involving multiple Blackstone entities and disclaimers of beneficial ownership could present challenges in fully understanding the ultimate control and influence over Medline Inc.
• Certain distributees of the in-kind shares are bound by a Lock Up Agreement, which restricts their ability to sell shares for a specified period, potentially impacting liquidity for those specific holders.

Future Outlook

Certain distributees of the in-kind shares have agreed to be bound by a Lock Up Agreement, which will restrict their ability to sell shares for a specified period following the transaction.

Management Comments

• Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein.
• Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
• Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

Industry Context

StockSavvy.ai notes that secondary offerings by major private equity sponsors like Blackstone are common strategies to monetize their investments in portfolio companies, often signaling a stage of maturity or a strategic exit from a significant holding. This type of transaction increases the public float and liquidity of the stock.

Related Party Transactions

• The sales of Class A Common Stock were conducted by Blackstone-affiliated entities and Stephen A. Schwarzman, who are considered related parties to Medline Inc. as 10% owners and potentially having director representation.

Stakeholder Impact

• Shareholders may experience increased liquidity in Medline Inc. stock due to the larger public float.
• The significant volume of shares sold by major beneficial owners could exert downward pressure on the share price in the short term.
• The transactions represent a partial monetization of investment for the selling Blackstone entities and Stephen A. Schwarzman.

Next Steps

• Certain distributees of the in-kind shares will be subject to a Lock Up Agreement, restricting future sales.

Key Dates

Recommendation

The significant sale of shares by major beneficial owners, including Blackstone entities, in a secondary offering suggests a strategic divestment by these large holders. While this can create downward pressure on the stock price and signals a reduction in their stake, it does not inherently reflect a deterioration in Medline's operational fundamentals. Investors should hold and monitor for further company-specific news and broader market reactions.

Keywords

Medline Inc., MDLN, Blackstone, Stephen A. Schwarzman, Form 4, insider trading, beneficial ownership, secondary offering, stock sale, private equity